Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis
RBR-2zh964cPhase 3Recruiting
- Sponsor
- Faculdade de Medicina da Universidade Federal Fluminense
- Start
- Sep 2024
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of platelet-rich plasma and hyaluronic acid in knee osteoarthritis (OA) (3 arms), sponsored by Faculdade de Medicina da Universidade Federal Fluminense. Started Sep 2024; status: recruiting.
02
Drugs
platelet-rich plasmahyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on RBR-2zh964c.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2zh964c.